The best-selling drugs of the next 5 years - Pharma Excipients

$ 19.00

4.5
(232)
In stock
Description

Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.Article by pharmaphorum.comThe data forecasts th

Current trends in drug delivery and excipients in the pharmaceutical industry - Pharma Excipients

Top 15 Best-Selling Drugs of 2018: Sales for most treatments grow year-over- year despite concerns over rising prices: GEN Edge: Vol 1, No 1

The top 20 drugs by 2021 sales

50 of 2021's best-selling pharmaceuticals

Top selling Drugs — Then Do Better

Top 10 Most Anticipated Drug Launches Of 2024

Radio Compass Blog, Latest Pharmaceutical Articles

Top pharma products by global sales 2022

The top 20 drugs by 2021 sales

REACH's Impact on the Pharmaceutical Industry

Cadila Healthcare surpasses Lupin to become 2nd most valuable pharma firm

Best selling drugs of 2023, Top 10 drugs by revenues, Best selling pharmaceuticals

Prediction of the Top 10 Best Selling Drugs in 2017(I) – Creative Biolabs Blog

Top pharmaceutical drugs - Statistics & Facts

Annual Report 2021